Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush

Posted
GLP-1 agonists are transforming the weight loss market. Experts weighed in on the changes they’re seeing, speaking in a panel discussion during the MedCity News INVEST Conference in Chicago. The post Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush appeared first on MedCity News.

Continue reading at MedCity News »

BioPharma, Pharma, biopharma nl, Chicago, Eli Lilly, GLP-1 drugs, Novo Nordisk, Obesity, wegovy, weight loss drugs